What type of study is this?

December 8, 2025Blood

Allogeneic hematopoietic stem cell transplantation for transfusion-dependent pyruvate kinase deficiency in Chinese children: A multicenter retrospective study

View Full Paper

Ask AI

Bookmark

Authors

RLRong LiuAnhui Medical University XWXiaodong WangChina Agricultural University XZXiaofan ZhuTianjin University of Sport

Discussion

Member takes

Implication

Multicenter analysis reveals high survival rates with allo-HSCT in pediatric pyruvate kinase deficiency, suggesting effective long-term outcomes despite GVHD risks.

Key Points

Allo-HSCT resulted in 97.1% overall survival for pediatric patients with pyruvate kinase deficiency, indicating significant efficacy.
The study involved a multicenter retrospective analysis of 35 children, determining safety and clinical outcomes post-transplant.
Graft-versus-host disease was assessed alongside overall survival metrics using the Kaplan–Meier methodology in this cohort.
Findings support allo-HSCT as an essential treatment for transfusion-dependent pyruvate kinase deficiency amid limited therapy options.

Cite This Study

Liu et al. (2025) studied this question.

synapsesocial.com/papers/69362f7f4fa91c937236e528 https://doi.org/10.1182/blood-2025-2521

View Full Paper

Ask AI

Bookmark

Implication

Multicenter analysis reveals high survival rates with allo-HSCT in pediatric pyruvate kinase deficiency, suggesting effective long-term outcomes despite GVHD risks.

Allogeneic hematopoietic stem cell transplantation for transfusion-dependent pyruvate kinase deficiency in Chinese children: A multicenter retrospective study

Discussion

Member takes

Implication

Key Points

Cite This Study

Allogeneic hematopoietic stem cell transplantation for transfusion-dependent pyruvate kinase deficiency in Chinese children: A multicenter retrospective study

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider